These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 2512833

  • 1. Pseudomonas hyperimmune globulin: antibiotic treatment of experimental Pseudomonas sepsis in burned mice.
    Holder IA, Neely AN.
    Antibiot Chemother (1971); 1989; 42():109-23. PubMed ID: 2512833
    [No Abstract] [Full Text] [Related]

  • 2. Use of passive immunotherapy in the treatment of experimental Pseudomonas aeruginosa infections in burns.
    Neely AN, Holder IA.
    Antibiot Chemother (1971); 1987; 39():26-40. PubMed ID: 3118788
    [No Abstract] [Full Text] [Related]

  • 3. Experimental studies of the pathogenesis of infections due to Pseudomonas aeruginosa. Treatment with intravenous immune globulin.
    Holder IA, Naglich JG.
    Am J Med; 1984 Mar 30; 76(3A):161-7. PubMed ID: 6424445
    [Abstract] [Full Text] [Related]

  • 4. Protective activity of an intravenous immune globulin (human) enriched in antibody against lipopolysaccharide antigens of Pseudomonas aeruginosa.
    Collins MS, Roby RE.
    Am J Med; 1984 Mar 30; 76(3A):168-74. PubMed ID: 6424446
    [Abstract] [Full Text] [Related]

  • 5. Therapy of experimental Pseudomonas burn wound sepsis with ciprofloxacin and Pseudomonas immune globulin.
    Collins MS, Tsay GC, Hector RF, Roby RE, Dorsey JH.
    Antibiot Chemother (1971); 1987 Mar 30; 39():222-32. PubMed ID: 3118784
    [No Abstract] [Full Text] [Related]

  • 6. A clinical trial of i.v. tetravalent hyperimmune Pseudomonas globulin G in burned patients.
    Hunt JL, Purdue GF.
    J Trauma; 1988 Feb 30; 28(2):146-51. PubMed ID: 3126302
    [Abstract] [Full Text] [Related]

  • 7. [Prevention using a Pseudomonas immunoglobulin in burn patients].
    Stuttmann R, Petrovici V, Hartert M.
    Infection; 1987 Feb 30; 15(1):80-4. PubMed ID: 3106234
    [Abstract] [Full Text] [Related]

  • 8. [Effectiveness of tobramycin and immunologic preparations in experimental Pseudomonas infection].
    Minukhin VV, Tsyganenko AIa.
    Antibiot Khimioter; 1989 Apr 30; 34(4):282-6. PubMed ID: 2502083
    [Abstract] [Full Text] [Related]

  • 9. Pseudomonas aeruginosa ribosomal vaccine. A comparison of the immunogenicity of vaccines from two different serotypes.
    Lieberman MM.
    Antibiot Chemother (1971); 1989 Apr 30; 42():193-202. PubMed ID: 2512837
    [No Abstract] [Full Text] [Related]

  • 10. Clinical evaluation of Pseudomonas hyperimmune globulin.
    Jones CE, Alexander JW, Fisher M.
    J Surg Res; 1973 Feb 30; 14(2):87-96. PubMed ID: 4632770
    [No Abstract] [Full Text] [Related]

  • 11. Efficiency of Pseudomonas aeruginosa vaccines in the prevention and treatment of Pseudomonas infections in burned patients.
    Ionescu A, Meitert E, Vasiliu S, Meitert T, Sima F, Savulian C, Milicescu S.
    Arch Roum Pathol Exp Microbiol; 1981 Feb 30; 40(4):323-32. PubMed ID: 6803737
    [No Abstract] [Full Text] [Related]

  • 12. Passive anti-PcrV treatment protects burned mice against Pseudomonas aeruginosa challenge.
    Neely AN, Holder IA, Wiener-Kronish JP, Sawa T.
    Burns; 2005 Mar 30; 31(2):153-8. PubMed ID: 15683685
    [Abstract] [Full Text] [Related]

  • 13. Experimental studies of the pathogenesis of infections due to Pseudomonas aeruginosa: immunization using divalent flagella preparations.
    Holder IA, Naglich JG.
    J Trauma; 1986 Feb 30; 26(2):118-22. PubMed ID: 2418208
    [Abstract] [Full Text] [Related]

  • 14. Clinical evaluation of Pseudomonas hyperimmune globulin and plasma.
    Jones CE, Alexander JW, Fisher MW.
    Surg Forum; 1970 Feb 30; 21():238-40. PubMed ID: 4105882
    [No Abstract] [Full Text] [Related]

  • 15. [Treatment of Pseudomonas aeruginosa septicemia in burns].
    Wang DW.
    Zhonghua Zheng Xing Shao Shang Wai Ke Za Zhi; 1987 Sep 30; 3(3):181-3, 237-8. PubMed ID: 3151607
    [No Abstract] [Full Text] [Related]

  • 16. A burned mouse model to evaluate anti-Pseudomonas activity of topical agents.
    Stieritz DD, Bondi A, McDermott D, Michaels ED.
    J Antimicrob Chemother; 1982 Feb 30; 9(2):133-40. PubMed ID: 6801006
    [No Abstract] [Full Text] [Related]

  • 17. Efficacy of antibodies against the N-terminal of Pseudomonas aeruginosa flagellin for treating infections in a murine burn wound model.
    Barnea Y, Carmeli Y, Gur E, Kuzmenko B, Gat A, Neville LF, Eren R, Dagan S, Navon-Venezia S.
    Plast Reconstr Surg; 2006 Jun 30; 117(7):2284-91. PubMed ID: 16772930
    [Abstract] [Full Text] [Related]

  • 18. Antiserum and antibiotic in the prophylaxis of burns against Pseudomonas aeruginosa.
    Jones RJ, Jackson DM, Lowbury EJ.
    Br J Plast Surg; 1966 Jan 30; 19(1):43-57. PubMed ID: 4956109
    [No Abstract] [Full Text] [Related]

  • 19. [Treatment of Pseudomonas aeruginosa infection in burn patients].
    Litovchenko PP, Nazarchuk LV, Degtiar NV, Abu-el-Khava MI, Gaĭduk VI.
    Klin Khir (1962); 1987 Jan 30; (3):24-7. PubMed ID: 3106703
    [No Abstract] [Full Text] [Related]

  • 20. Immunization against Pseudomonas in infection after thermal injury.
    Wesley J, Fisher A, Fisher MW.
    J Infect Dis; 1974 Nov 30; 130 Suppl(0):S152-8. PubMed ID: 4138646
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.